OpenAI has launched ChatGPT Health to all US users, enabling integration of personal medical records and health data to enhance AI-driven health queries using its latest GPT-5.6 model, which the company says demonstrates reasoning approaching clinical expertise.
- ChatGPT Health connects user medical records and health-tracking apps.
- Latest GPT-5.6 model claims improved clinical reasoning abilities.
- OpenAI emphasizes tool supports, not replaces, professional medical advice.
What happened
OpenAI has officially rolled out ChatGPT Health to all logged-in users aged 18 and older in the United States across multiple platforms including web and iOS. This launch allows users to connect their medical records from healthcare providers and lifestyle apps such as Apple Health and Weight Watchers directly to ChatGPT for health-related inquiries.
The service is powered by OpenAI’s newly released GPT-5.6 Sol model, promoted as the company’s strongest health model yet. ChatGPT Health integrates health data into the main chat interface, enabling users to ask personalized questions about their medical information once permission is granted, while promising enhanced encryption to protect sensitive data.
Why it matters
OpenAI’s announcement positions ChatGPT Health as a pioneering AI product capable of reasoning at or near clinician levels, potentially transforming how individuals seek preliminary health information and manage personal wellness data. This marks a significant advancement in AI healthcare applications by coupling conversational AI with real medical records and health metrics.
However, the rollout comes amid scrutiny of AI’s medical advice reliability, highlighted by a recent lawsuit alleging harmful health guidance from ChatGPT. OpenAI acknowledges these concerns by stressing that ChatGPT Health is designed to support—not replace—professional medical care, underscoring the need for cautious use while regulatory and clinical frameworks evolve.
What to watch next
Stakeholders should monitor user adoption rates and regulatory responses to OpenAI’s health-focused AI, especially how privacy protections and accuracy standards will be upheld as more sensitive health data is shared with AI services. The coming months may also reveal further independent studies assessing the model’s clinical reasoning claims.
Additionally, the broader market reaction to this deployment may influence competitive moves by other AI and health technology companies seeking to integrate AI-assisted healthcare tools. Legal developments following the recent lawsuit could also impact how such AI health services are governed and trusted by the public.